Venture Partners L P Sofinnova VI's Net Worth

-$14.9 Million

Estimate Recalculated Nov 1, 2024 03:55AM EST

Who is Venture Partners L P Sofinnova VI?

Venture Partners L P Sofinnova VI does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., MARINUS PHARMACEUTICALS INC, Anthera Pharmaceuticals Inc, and Ocera Therapeutics, Inc..

SEC CIK

Venture Partners L P Sofinnova VI's CIK is 0001211465

Past Insider Trading and Trends

2010 was Venture Partners L P Sofinnova VI's most active year for acquiring shares with 24 total transactions. Venture Partners L P Sofinnova VI's most active month to acquire stocks was the month of February. 2007 was Venture Partners L P Sofinnova VI's most active year for disposing of shares, totalling 9 transactions. Venture Partners L P Sofinnova VI's most active month to dispose stocks was the month of February. 2010 saw Venture Partners L P Sofinnova VI paying a total of $12,560,454.34 for 4,177,621 shares, this is the most they've acquired in one year. In 2007 Venture Partners L P Sofinnova VI cashed out on 5,645,711 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $1.3911

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-35.31%
-750.68K
$1.39
-$1,042,698.68
1.38M
Oct 20
Form 4
+71.72%
2.13M
$8.00
$6,005,464.00
5.09M
Aug 5
Form 3
—
0
—
—
0
No matching records found

Anthera Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+30.31%
4.07M
$6.13
$12,560,454.34
17.51M
Mar 4
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Orexigen Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+82.80%
2.82M
—
—
6.23M
May 1
Form 3
—
0
—
—
0
No matching records found

Ocera Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-33.00%
-410.02K
—
—
832.47K
Mar 18
Form 3
—
0
—
—
0
Form 4
+45.95%
391.17K
$6.03
$2,357,322.78
1.24M
Jul 15
No matching records found